Fortrea Holdings Inc. FTREV 深 沪
等待开盘 07-07 09:30:00 美东时间
34.01
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 34.01
- 总市值 301.33万
- 52周最高 35.76
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 30.10
- 委 比 0.00%
- 总股本 8.86万
- 历史最高 35.76
- 量 比 0
- 振 幅 0.00%
- 历史最低 30.10
- 每 手 1
- 风险率 0.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多分析师解读医疗健康企业：Viridian Therapeutics（VRDN）与Fortrea Holdings Inc.（FTRE）
医疗保健领域两名分析师分别对VRDN（维里迪安治疗公司）、FTRE（富驰控股有限公司）给出看涨评级。 VRDN相关关键数据：上周五收盘价17.90美元，华尔街共...
06-30 10:32
Fortrea Appoints New CFO and Reaffirms 2026 Outlook
The latest update is out from Fortrea Holdings Inc. ( ($FTRE) ). On June 26, 20...
06-27 04:57
Fortrea names Jason Knoblauch as CFO
Fortrea (FTRE) has appointed Jason Knoblauch as chief financial officer, effective July 6, 2026. Knoblauch joins Fortrea from Clario, where he served as CFO. He will succeed Jill McConnell, who is ste...
06-26 19:22
Fortrea names Jason Knoblauch CFO, succeeding Jill McConnell
Fortrea names Jason Knoblauch CFO, succeeding Jill McConnell Fortrea appointed Jason Knoblauch as chief financial officer, effective July 6, 2026. Knoblauch will succeed Jill McConnell, who is stepping down. He joins from Clario, where he served as CFO; he previously held CFO roles at Curia. Earlier
06-26 19:10
Fortrea reiterates 2026 revenue outlook of $2.55 billion-$2.65 billion
Fortrea reiterates 2026 revenue outlook of $2.55 billion-$2.65 billion Fortrea reiterated full-year 2026 guidance, projecting revenue of $2.55 billion-$2.65 billion. Adjusted EBITDA outlook held at $190 million-$220 million. Guidance reaffirmation accompanied a CFO transition, with Jason Knoblauch s
06-26 19:00
Fortrea to report first-quarter results, host conference call
Fortrea to report first-quarter results, host conference call Fortrea will release first-quarter 2026 financial results before market open on May 5, 2026. Management will host earnings conference call at 8:00 a.m. ET on May 5, 2026. Live webcast will be available via investors.fortrea.com . Disclaim
04-21 20:45
Fortrea Appoints Oren Cohen as CMO and Scott Dove as President of Clinical Pharmacology Services
Fortrea Appoints Oren Cohen as CMO and Scott Dove as President of Clinical Pharmacology Services Fortrea Holdings Inc. has expanded its executive team, appointing Oren Cohen, MD, as Chief Medical Officer and Scott Dove, PhD, as President of Clinical Pharmacology Services. Dr. Cohen will now focus so
02-17 20:00
Fortrea Holdings Inc. to Release Fourth Quarter and Full Year Financial Results
Fortrea Holdings Inc. to Release Fourth Quarter and Full Year Financial Results Fortrea Holdings Inc. will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026. The results will be available on the Fortrea Investor Relations website.
01-29 21:08
Fortrea upgraded at Evercore ISI on management changes
Fortrea Holdings (FTRE) traded higher on Tuesday after Evercore ISI upgraded the contract research organization, citing positives in its recent leadership transition, in which a veteran life sciences ...
01-07 02:14
Barclays upgrades Fortrea Holdings Inc. (FTRE) to a Hold
In a report released today, Luke Sergott from Barclays upgraded Fortrea Holding...
2025-12-15 17:25
